Matthew D. Howe - Concepedia

Author

Matthew D. Howe

The University of Texas Health Science Center at Houston ORCID

Also Known As

Howe, Matthew, Howe, Matthew D., Matthew D Howe, Matthew D. Howe, Matthew Howe, Matthew R Howe

Publications

413

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at Houston Butler Hospital Yale University Brown University Kaiser Permanente Redwood City Medical Center

About

Matthew D. Howe is an author at The University of Texas Health Science Center at Houston specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	156
2	Social Sciences	2	2	85
3	Health Sciences	1	1	12
4	Cell Biology	1	1	24
5	Cognitive Science	1	1	46

Matthew D. Howe

Publications

296

Citations

H-Index

Page 1

	Year	Citations
Hippocampal theta, gamma, and theta-gamma coupling: effects of aging, environmental change, and cholinergic activation Tara K. Jacobson, Matthew D. Howe, Brandy Schmidt, Journal of Neurophysiology NeuropsychologyAgingBrain FunctionHippocampal ThetaSocial Sciences	2013	46
Inhibition of calcium/calmodulin‐dependent protein kinase kinase (Ca<scp>MKK</scp>) exacerbates impairment of endothelial cell and blood–brain barrier after stroke Ping Sun, Fan Bu, Jia‐Wei Min, European Journal of Neuroscience	2018	40
Transforming growth factor-β promotes basement membrane fibrosis, alters perivascular cerebrospinal fluid distribution, and worsens neurological recovery in the aged brain after stroke Matthew D. Howe, J. Weldon Furr, Yashasvee Munshi, GeroScience Neurodegenerative DiseasesNeuroregenerationMedicineCerebrospinal FluidCerebrospinal Fluid Distribution	2019	39
Fibronectin induces the perivascular deposition of cerebrospinal fluid–derived amyloid-β in aging and after stroke Matthew D. Howe, Louise Atadja, J. Weldon Furr, Neurobiology of Aging Neurodegenerative DiseasesMedicineDegenerative PathologyVascular BiologyNeuroscience	2018	35
Biomarkers of Alzheimer’s disease: Past, present and future clinical use Joanna Georgakas, Matthew D. Howe, Louisa I. Thompson, Biomarkers in Neuropsychiatry	2023	34
Serum Markers of Blood-Brain Barrier Remodeling and Fibrosis as Predictors of Etiology and Clinicoradiologic Outcome in Intracerebral Hemorrhage Matthew D. Howe, Liang Zhu, Lauren Sansing, Frontiers in Neurology	2018	28
The ubiquitin ligase UBE4B regulates amyloid precursor protein ubiquitination, endosomal trafficking, and amyloid β42 generation and secretion Monica Gireud, Sahily Reyes‐Esteves, Ritika Tewari, Molecular and Cellular Neuroscience Protein SecretionProtein FunctionProtein FoldingAmyloid β42 GenerationMolecular Biology	2020	24
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease Matthew D. Howe, Karysa Britton, Hannah E. Joyce, Alzheimer s Research & Therapy	2024	15
Sex-specific Association of Matrix Metalloproteinases with Secondary Injury and Outcomes after Intracerebral Hemorrhage Matthew D. Howe, J. Weldon Furr, Liang Zhu, Journal of Stroke and Cerebrovascular Diseases Health SciencesClinical InjuryMatrix MetalloproteinasesPathologyHemostasis	2019	12
Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval Matthew D. Howe, Karysa Britton, Hannah E Joyce, The Journal of Prevention of Alzheimer s Disease	2023	12

Page 1